U.S. Logistics Stock News

A high profile antitrust lawsuit aimed at stopping Paramount’s planned US$110b acquisition of Warner Bros. Discovery is putting a spotlight on how regulation can reshape entire sectors, not just one deal. With US$80b of new debt, a US$650m quarterly ticking fee risk, and talk of US$6b in cost cuts, investors are reassessing which stocks could be helped if big media consolidation is slowed or becomes more expensive. This article walks through 3 stocks from the Media Consolidation Antitrust...

In June 2026, Elastic N.V. launched expanded observability capabilities, including native Prometheus and PromQL support, Kubernetes investigation workflows, and automated migration tools from Datadog and Grafana, all built on its columnar metrics engine. An interesting angle is Elastic’s attempt to unify logs, metrics, and traces on a single backend while easing Prometheus and Grafana migrations, potentially making it easier for enterprises to consolidate observability tools. We’ll now...

Alaska Air Group has recently drawn attention as it progresses with integrating Hawaiian Airlines ahead of its July 2026 earnings report, while being recognized for strong on-time performance and operational reliability. Analysts and investors are increasingly focused on whether the combination of Hawaiian Airlines and Alaska’s operational strengths can offset rising labor and integration costs over time. We’ll now examine how optimism around Hawaiian Airlines integration ahead of earnings...

Broadstone Net Lease (BNL) recently entered a joint venture to develop an advanced technology facility in Colorado, committing about $303 million under a long-term triple-net lease with scheduled rent increases. See our latest analysis for Broadstone Net Lease. The new Colorado project lands at a time when Broadstone Net Lease’s share price has been firming, with a year to date share price return of 25.66% and a 1 year total shareholder return of 44.75%. This suggests momentum has been...

uniQure (QURE) has drawn fresh attention after a strong rebound in its share price over the past month and past 3 months, prompting investors to reassess the gene therapy company’s risk and return trade off. See our latest analysis for uniQure. Over the past year, uniQure’s 182.47% total shareholder return and 285.92% three year total shareholder return contrast with a recent 3.59% one day share price decline. This suggests strong longer term momentum alongside short term volatility as...

Revvity (RVTY) is back in focus after announcing that its Revvity Signals Software business has joined Anthropic's Model Context Protocol connector directory, linking Signals AI with Claude and Claude Science for scientific research workflows. See our latest analysis for Revvity. Revvity's latest AI partnership lands as the stock trades at US$111.11, with a 30 day share price return of 11.49% and 90 day share price return of 18.82%. The 1 year total shareholder return of 13.16% contrasts with...

Super Micro Computer stock has given investors a very large 5 year return, yet at around US$27.66 the valuation work still points to a discount, with both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples suggesting the shares may be trading below what the fundamentals imply. A roughly 7x gain over 5 years leaves long term holders with substantial gains, yet the current valuation signals still flag the stock as pricing in relatively modest expectations compared...

Applied Materials stock has delivered very strong returns over the past few years, yet its valuation checks currently lean towards the expensive side rather than a clear bargain. After such a sharp repricing, the question is how much of the semiconductor and AI equipment story is already reflected in today’s share price. Applied Materials has returned about 366.6% over 5 years, which sets a high bar for any further upside case to be convincing. Expectations around continued demand for...

Vertex Pharmaceuticals (VRTX) stock is in focus after regulators expanded US approval of its gene therapy CASGEVY to children as young as 2 with sickle cell disease or transfusion dependent beta thalassemia. See our latest analysis for Vertex Pharmaceuticals. The latest FDA approval comes after a volatile few sessions for Vertex Pharmaceuticals, with the share price down 9.32% over the past week but showing a 30 day share price return of 7.94% and a 5 year total shareholder return of 141.04%...

Cardinal Health has delivered very strong share price gains over the past five years, yet its current valuation checks lean expensive, which raises the question of how much of that strength is already reflected in the stock. Cardinal Health has returned about 365.1% over five years. This puts extra focus on whether today’s price still offers an appealing entry point or mainly reflects past gains. Recent enthusiasm around Cardinal Health’s specialty healthcare and higher margin growth...

Alphabet stock has roughly doubled over the past five years, and at a recent close of US$352.51, investors now face a more nuanced valuation picture. The Discounted Cash Flow (DCF) intrinsic value estimate points to a level close to the current price, while earnings-based multiples still screen the shares as undervalued. Alphabet has delivered about 185.5% over five years, which puts extra weight on whether today’s valuation still leaves enough room for further compounding from here. On the...

Brinker International stock has logged a very large 3 year gain while both the Discounted Cash Flow (DCF) intrinsic value estimate and traditional earnings multiples still suggest the shares trade at a discount to what the business may be worth. Over the last 3 years, Brinker International has delivered a very large total return of 406.6%, which puts extra focus on whether the current price still leaves room for more upside based on fundamentals. Index inclusion in the Russell 2000 Defensive...

F5 has appointed Cathy Peterman as Executive Vice President and Chief People Officer. Peterman brings experience from senior roles at Wayfair and Amazon in scaling talent and organizational change. The appointment highlights F5’s focus on talent development and AI driven transformation across the company. For investors tracking F5, ticker NasdaqGS:FFIV, this people leadership move comes as the stock trades at $420.95, with a return of 64.0% year to date and 184.2% over three years. The...

Visteon (VC) continues to attract attention after recent trading, with the stock last closing at $103.54. Investors are weighing this price against the company’s current fundamentals and recent share price performance. See our latest analysis for Visteon. Recent trading has been weaker, with a 1-day share price return of 2.85% lower and a 30-day share price return down 12.58%. The 1-year total shareholder return has fallen 8.36%, which contrasts with a stronger 90-day share price return of...

GEO Group (GEO) has drawn fresh attention after announcing a five year support services contract with U.S. Immigration and Customs Enforcement for the 1,188 bed Big Horn Facility in Hudson, Colorado. See our latest analysis for GEO Group. GEO Group’s new Big Horn Facility contract lands after a period of strong share price momentum, with the stock posting a 90 day share price return of 68.94% and a five year total shareholder return of 365.23%. If this kind of contract driven story has your...

Global investors are watching energy prices, inflation data, and central bank decisions closely, and that spotlight often turns to Aerospace And Defense stocks. This group sits at the crossroads of government spending, security priorities, and long-term industrial projects, which can appeal to investors looking for exposure that is not tied only to consumer demand or short term economic cycles. Using an Aerospace And Defense screener that focuses on companies manufacturing or providing...

UnitedHealth Group’s share price has climbed 46.6% over the past year, yet the valuation checks point to a more mixed picture rather than a straightforward bargain or a clear overvaluation. Over the last 12 months, UnitedHealth Group has returned 46.6%, which puts the recent rally front and center for anyone thinking about what the stock is now worth. Investor focus on margin resilience and new offerings like expanded preventive care coverage and digital benefits may support earnings...

Netflix (NasdaqGS:NFLX) has secured exclusive rights to stream the MLB Home Run Derby as a live event. The broadcast marks Netflix's first major live U.S. sports event, extending the company beyond on demand entertainment. The move places Netflix in more direct competition with platforms that already carry live sports content. For investors watching Netflix, this step into live sports comes on top of its established position in subscription video on demand. The company has built its...

Altria Group (MO) is in focus as it continues expanding smoke free nicotine offerings alongside its long standing cigarette and oral tobacco portfolio, prompting investors to reassess how this product mix fits current income and value expectations. See our latest analysis for Altria Group. At a share price of US$71.87, Altria Group has seen strong recent momentum, with a 90 day share price return of 9.52% and a year to date share price return of 25.41%, backed by a 1 year total shareholder...

Figma stock has rebounded in recent weeks, but with the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples both pointing to an overvaluation, the recent share price recovery sits at odds with what the valuation checks are implying. Year to date, Figma is still down 37.1%, which means the stock is recovering from a weak start rather than trading near its highs. Optimism around AI driven growth and stronger institutional visibility can support higher expectations...

Russia’s deepening fuel crisis and the spread of Ukrainian drone attacks into Moscow and key energy hubs are reshaping how risk is priced across global defense and aerospace stocks. Supply chains, military technology, and energy security are all in sharper focus, and some companies in our Global Defense and Aerospace screener sit directly in the path of this shift. For investors deciding whether to lean in or stay cautious around this theme, the details matter. This article examines 3 stocks...

AMD Ventures has backed AI startup Turing Inc., which is adopting AMD AI accelerators for consumer and autonomous driving applications. Turing Inc. is shifting part of its AI workloads from Nvidia GPUs to AMD hardware, signaling direct commercial uptake of AMD’s AI products. Reports of delays in Nvidia’s upcoming AI rack system are creating potential openings for AMD in data center deployments with cloud providers and hyperscalers. Advanced Micro Devices (NasdaqGS:AMD) is seeing fresh...

Amgen has initiated multiple nationwide recalls of certain lots of Corlanor (ivabradine) and Sensipar (cinacalcet). The recalls are tied to quality control issues, including foreign substances and current Good Manufacturing Practice (cGMP) deviations. These actions affect several product lots across the United States and raise questions around manufacturing controls and oversight. For investors following Amgen, NasdaqGS:AMGN, the latest recalls come at a time when the stock is trading...

Lumen Technologies recently announced Lumen Defender Advanced Managed Detection and Response for Palo Alto Networks’ Cortex XSIAM, combining its managed detection, automation and Black Lotus Labs network threat intelligence with Palo Alto Networks’ AI-driven SOC platform to help enterprises modernize security operations. This collaboration reinforces Palo Alto Networks’ position in AI-enabled cybersecurity by extending its platform into co-managed and fully managed SOC models powered by...